Observational Study
Prevalence of Cognitive Impairment in Dialysis Patients in Gauteng Province, South Africa
Tebogo Ndhlovu*, Lisa Repsold, Kwazi Ndlovu and Albert Muranda
Published: 26 August, 2024 | Volume 8 - Issue 2 | Pages: 103-113
Introduction: Cognitive impairment is defined as a new deficit in at least two areas of cognitive functioning. These may include disturbances in memory, executive functioning, attention or speed of information processing, perceptual motor abilities, or language. It has been shown that cognitive impairment is associated with the severity of kidney disease.
Methods: The study was a descriptive research design, with participants purposively sampled from the general chronic kidney disease population which included haemodialysis and peritoneal dialysis patients at Steve Biko Academic Hospital in Pretoria, Gauteng Province, South Africa. Hundred and fifty-one participants (76 hemodialysis & 75 peritoneal dialysis patients), 58% were males, and 42% were females aged 19-61 years. To establish the prevalence of cognitive impairment by testing the level of cognition the Mini-Mental State Examination was utilized to provide a brief screening test to quantitatively assess the cognitive abilities and cognitive changes of patients while on dialysis.
Results: Ninety-nine percent (99%) of the recruited population reported no cognitive impairment, irrespective of dialysis modality, demographic characteristics, and socio-economic status.
Conclusion: Despite the findings highlighting that the majority of the chronic kidney disease population at Steve Biko Academic Hospital reported no cognitive impairment, it is crucial to increase awareness of the potential effects of cognitive impairment on daily activities, quality of life, and treatment adherence. Early detection and management of cognitive impairment can significantly impact the quality of life and adherence to treatment among these patients. Further research is needed to understand the prevalence and impact of cognitive impairment in different populations and to develop effective interventions for its prevention and management.
Read Full Article HTML
DOI: 10.29328/journal.jcn.1001136
Cite this Article
Read Full Article PDF
Keywords:
Chronic Kidney Disease, cognitive impairment, haemodialysis, peritoneal dialysis
References
- Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis. PLoS One. 2016 Jul 6;11(7):e0158765. doi: 10.1371/journal.pone.0158765. PMID: 27383068; PMCID: PMC4934905.
- Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A. Evolving importance of kidney disease: from subspecialty to global health burden. Lancet. 2013 Jul 13;382(9887):158-69. doi: 10.1016/S0140-6736(13)60439-0. Epub 2013 May 31. PMID: 23727165.
- Onalan E. The relationship between monocyte to high-density lipoprotein cholesterol ratio and diabetic nephropathy. Pak J Med Sci. 2019 Jul-Aug;35(4):1081-1086. doi: 10.12669/pjms.35.4.534. PMID: 31372147; PMCID: PMC6659096.
- Samsu N. Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. Biomed Res Int. 2021 Jul 8;2021:1497449. doi: 10.1155/2021/1497449. PMID: 34307650; PMCID: PMC8285185.
- Khan FA, Fatima SS, Khan GM, Shahid S. Evaluation of kidney injury molecule-1 as a disease progression biomarker in diabetic nephropathy. Pak J Med Sci. 2019;35(4):992–996. doi: 10.12669/pjms.35.4.154.
- Chuasuwan A, Pooripussarakul S, Thakkinstian A, Ingsathit A, Pattanaprateep O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual Life Outcomes. 2020;18(1):191. doi: 10.1186/s12955-020-01449-2.
- Etgen T, Chonchol M, Förstl H, Sander D. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol. 2012;35(5):474-82. doi: 10.1159/000338135. Epub 2012 May 3. PMID: 22555151.
- Muranda A.Z, Repsold L, Ndhlovu T. "POS-678 Factors influencing fluid restriction nonadherence amongst patients undergoing chronic dialysis at Steve Biko Academic Hospital, Pretoria, South Africa", Kidney International Reports, 2021.
- Tilki HE, Akpolat T, Tunali G, Kara A, Onar MK. Effects of haemodialysis and continuous ambulatory peritoneal dialysis on P300 cognitive potentials in uraemic patients. Ups J Med Sci. 2004;109(1):43-8. doi: 10.3109/2000-1967-109. PMID: 15124952.
- Jönsson L, Lindgren P, Wimo A, Jönsson B, Winblad B. Costs of Mini Mental State Examination-related cognitive impairment. Pharmacoeconomics. 1999 Oct;16(4):409-16. doi: 10.2165/00019053-199916040-00008. PMID: 10623368.
- Madero M, Gul A, Sarnak MJ. Cognitive function in chronic kidney disease. Semin Dial. 2008 Jan-Feb;21(1):29-37. doi: 10.1111/j.1525-139X.2007.00384.x. PMID: 18251955.
- Wimo A, Winblad B. Pharmacoeconomics of mild cognitive impairment. Acta Neurol Scand Suppl. 2003;179:94-9. doi: 10.1034/j.1600-0404.107.s179.13.x. PMID: 12603255.
- Lin PJ, Neumann PJ. The economics of mild cognitive impairment. Alzheimers Dement. 2013 Jan;9(1):58-62. doi: 10.1016/j.jalz.2012.05.2117. Epub 2012 Nov 8. PMID: 23141385.
- Ismail Z, Rajji TK, Shulman KI. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry. 2010;25(2):111–20.
- Masson P, Wu S, Duthie FA, Kelly PJ, Craig JC, Gillespie D, Parker D, Palmer S, Whiteley W, Webster AC. Cognition in kidney transplant recipients: a systematic review and meta-analysis. Nephrol Dial Transplant. 2016;31 Suppl 1: i565.
- Berkman ND, Sheridan SL, Donahue KE, Halpern DJ, Viera A, Crotty K, et al. Health literacy interventions and outcomes: an updated systematic review. Evid Rep Technol Assess (Full Rep). 2011 Mar;(199):1-941. PMID: 23126607; PMCID: PMC4781058.
- Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. PMID: 1202204.
- Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment(4th) 2014;. New York, NY: Oxford University Press.
- O'Connor DW, Pollitt PA, Hyde JB, Fellows JL, Miller ND, Brook CP, Reiss BB. The reliability and validity of the Mini-Mental State in a British community survey. J Psychiatr Res. 1989;23(1):87-96. doi: 10.1016/0022-3956(89)90021-6. PMID: 2666647.
- Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 1992 Sep;40(9):922-35. doi: 10.1111/j.1532-5415.1992.tb01992.x. PMID: 1512391.
- Bondi M. W., Salmon D. P., & Kaszniak A. W. (1996). The neuropsychology of dementia In Grant I. & Adams K. M. (Eds.), Neuropsychological assessment of neuropsychiatric disorders(pp. 164–199). New York: Oxford University Press.
- Engedal K, Haugen P, Gilje K, Laake P. Efficacy of short mental tests in the detection of mental impairment in old age. Compr Gerontol A. 1988 Jun;2(2):87-93. PMID: 3228822.
- Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, et al. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2. Update in: Cochrane Database Syst Rev. 2021 Jul 27;7:CD010783. doi: 10.1002/14651858.CD010783.pub3. PMID: 25740785; PMCID: PMC6464748.
- Andrews MM, Haviland MG, Saltzman SB. Using health literacy tools to enhance patient education. Nephrology nursing journal: journal of the American Nephrology Nurses' Association. 2015; 42(2): 183-193.
- Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005 Jan 25;64(2):277-81. doi: 10.1212/01.WNL.0000149519.47454.F2. PMID: 15668425.
- Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A. 15-year longitudinal study of blood pressure and dementia. Lancet. 1996 Apr 27;347(9009):1141-5. doi: 10.1016/s0140-6736(96)90608-x. PMID: 8609748.
- Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 2014 Aug;13(8):788-94. doi: 10.1016/S1474-4422(14)70136-X. Erratum in: Lancet Neurol. 2014 Nov;13(11):1070. PMID: 25030513.
- Hughes D, Judge C, Murphy R, Loughlin E, Costello M, Whiteley W, Bosch J, O'Donnell MJ, Canavan M. Association of Blood Pressure Lowering With Incident Dementia or Cognitive Impairment: A Systematic Review and Meta-analysis. JAMA. 2020 May 19;323(19):1934-1944. doi: 10.1001/jama.2020.4249. PMID: 32427305; PMCID: PMC7237983.
- Yamamoto Y, Nagakane Y, Tomii Y, Akiguchi I. High Morning and Bedtime Home Blood Pressures Strongly Predict for Post-Stroke Cognitive Impairment. J Stroke Cerebrovasc Dis. 2016 Aug;25(8):1856-63. doi: 10.1016/j.jstrokecerebrovasdis.2016.04.001. Epub 2016 May 2. PMID: 27156901.
- Ding J, Sigurðsson S, Jónsson PV, Eiriksdottir G, Meirelles O, Kjartansson O, et al. Space and location of cerebral microbleeds, cognitive decline, and dementia in the community. Neurology. 2017 May 30;88(22):2089-2097. doi: 10.1212/WNL.0000000000003983. Epub 2017 May 3. PMID: 28468844; PMCID: PMC5447401.
- Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009 Nov;8(11):1006-18. doi: 10.1016/S1474-4422(09)70236-4. Epub 2009 Sep 24. PMID: 19782001.
- Kelly D, Rothwell PM. Disentangling the multiple links between renal dysfunction and cerebrovascular disease. J Neurol Neurosurg Psychiatry. 2020 Jan;91(1):88-97. doi: 10.1136/jnnp-2019-320526. Epub 2019 Sep 11. PMID: 31511306; PMCID: PMC6952845.
- Ninomiya T, Perkovic V, Verdon C, Barzi F, Cass A, Gallagher M, Jardine M, Anderson C, Chalmers J, Craig JC, Huxley R. Proteinuria and stroke: a meta-analysis of cohort studies. Am J Kidney Dis. 2009 Mar;53(3):417-25. doi: 10.1053/j.ajkd.2008.08.032. Epub 2008 Dec 13. PMID: 19070947.
- Major RW, Cheng MRI, Grant RA, Shantikumar S, Xu G, Oozeerally I, et al. Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS One. 2018 Mar 21;13(3):e0192895. doi: 10.1371/journal.pone.0192895. PMID: 29561894; PMCID: PMC5862400.
- O'Sullivan ED, Hughes J, Ferenbach DA. Renal Aging: Causes and Consequences. J Am Soc Nephrol. 2017 Feb;28(2):407-420. doi: 10.1681/ASN.2015121308. Epub 2016 Nov 15. PMID: 28143966; PMCID: PMC5280008.
- Adjei DN, Stronks K, Adu D, Snijder MB, Modesti PA, Peters RJG, Vogt L, Agyemang C. Relationship between educational and occupational levels, and Chronic Kidney Disease in a multi-ethnic sample- The HELIUS study. PLoS One. 2017 Nov 1;12(11):e0186460. doi: 10.1371/journal.pone.0186460. PMID: 29091928; PMCID: PMC5665422..
- Plantinga LC, Johansen K, Crews DC, Shahinian VB, Robinson BM, Saran R, Burrows NR, Williams DE, Powe NR; CDC CKD Surveillance Team. Association of CKD with disability in the United States. Am J Kidney Dis. 2011 Feb;57(2):212-27. doi: 10.1053/j.ajkd.2010.08.016. Epub 2010 Oct 30. PMID: 21036441; PMCID: PMC3025052.
- Winkelmayer WC, Patrick AR, Liu J, Brookhart MA, Setoguchi S. The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol. 2011 Feb;22(2):349-57. doi: 10.1681/ASN.2010050459. Epub 2011 Jan 13. PMID: 21233416; PMCID: PMC3029907.
- Kumai Y, Kamouchi M, Hata J, Ago T, Kitayama J, Nakane H, Sugimori H, Kitazono T; FSR Investigators. Proteinuria and clinical outcomes after ischemic stroke. Neurology. 2012 Jun 12;78(24):1909-15. doi: 10.1212/WNL.0b013e318259e110. Epub 2012 May 16. PMID: 22592359.
- van Uden IW, van der Holst HM, Tuladhar AM, van Norden AG, de Laat KF, Rutten-Jacobs LC, et al. White Matter and Hippocampal Volume Predict the Risk of Dementia in Patients with Cerebral Small Vessel Disease: The RUN DMC Study. J Alzheimers Dis. 2016;49(3):863-73. doi: 10.3233/JAD-150573. PMID: 26529206.
- Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJM, et al. Cerebral blood flow in small vessel disease: A systematic review and meta-analysis. J Cereb Blood Flow Metab. 2016 Oct;36(10):1653-1667. doi: 10.1177/0271678X16662891. Epub 2016 Aug 5. PMID: 27496552; PMCID: PMC5076792.
- Brickman AM, Guzman VA, Gonzalez-Castellon M, Razlighi Q, Gu Y, Narkhede A, et al. Cerebral autoregulation, beta amyloid, and white matter hyperintensities are interrelated. Neurosci Lett. 2015 Apr 10;592:54-8. doi: 10.1016/j.neulet.2015.03.005. Epub 2015 Mar 4. PMID: 25748319; PMCID: PMC4430835.
- Thal DR, Attems J, Ewers M. Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies. J Alzheimers Dis. 2014;42 Suppl 4:S421-9. doi: 10.3233/JAD-141461. PMID: 25227313.
- Weller RO, Subash M, Preston SD, Mazanti I, Carare RO. Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol. 2008 Apr;18(2):253-66. doi: 10.1111/j.1750-3639.2008.00133.x. PMID: 18363936; PMCID: PMC8095597.
- Chatterjee S, Peters SA, Woodward M, Mejia Arango S, Batty GD, Beckett N, et al. Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia. Diabetes Care. 2016 Feb;39(2):300-7. doi: 10.2337/dc15-1588. Epub 2015 Dec 17. PMID: 26681727; PMCID: PMC4722942.
- Barbiellini Amidei C, Fayosse A, Dumurgier J, Machado-Fragua MD, Tabak AG, van Sloten T, Kivimäki M, Dugravot A, Sabia S, Singh-Manoux A. Association Between Age at Diabetes Onset and Subsequent Risk of Dementia. JAMA. 2021 Apr 27;325(16):1640-1649. doi: 10.1001/jama.2021.4001. PMID: 33904867; PMCID: PMC8080220.
- Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2020 Sep;19(9):609-633. doi: 10.1038/s41573-020-0072-x. Epub 2020 Jul 24. PMID: 32709961; PMCID: PMC7948516.
- Kellar D, Craft S. Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches. Lancet Neurol. 2020 Sep;19(9):758-766. doi: 10.1016/S1474-4422(20)30231-3. Epub 2020 Jul 27. PMID: 32730766; PMCID: PMC9661919.
- Hamed SA. Brain injury with diabetes mellitus: evidence, mechanisms and treatment implications. Expert Rev Clin Pharmacol. 2017 Apr;10(4):409-428. doi: 10.1080/17512433.2017.1293521. Epub 2017 Feb 22. PMID: 28276776.
- GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10225):709-733. doi: 10.1016/S0140-6736(20)30045-3. Epub 2020 Feb 13. PMID: 32061315; PMCID: PMC7049905.
- Hobson P, Lewis A, Nair H, Wong S, Kumwenda M. How common are neurocognitive disorders in patients with chronic kidney disease and diabetes? Results from a cross-sectional study in a community cohort of patients in North Wales, UK. BMJ Open. 2018 Dec 4;8(12):e023520. doi: 10.1136/bmjopen-2018-023520. PMID: 30518585; PMCID: PMC6286490.
- Chang AR, Grams ME, Navaneethan SD. Bariatric Surgery and Kidney-Related Outcomes. Kidney Int Rep. 2017 Mar;2(2):261-270. doi: 10.1016/j.ekir.2017.01.010. Epub 2017 Jan 26. PMID: 28439568; PMCID: PMC5399773.
- Friedman AN, Kaplan LM, le Roux CW, Schauer PR. Management of Obesity in Adults with CKD. J Am Soc Nephrol. 2021 Apr;32(4):777-790. doi: 10.1681/ASN.2020101472. Epub 2021 Feb 18. PMID: 33602674; PMCID: PMC8017542.
- Luchsinger JA, Gustafson DR. Adiposity and Alzheimer's disease. Curr Opin Clin Nutr Metab Care. 2009 Jan;12(1):15-21. doi: 10.1097/MCO.0b013e32831c8c71. PMID: 19057182; PMCID: PMC2771208.
- Wennberg AMV, Wu MN, Rosenberg PB, Spira AP. Sleep Disturbance, Cognitive Decline, and Dementia: A Review. Semin Neurol. 2017 Aug;37(4):395-406. doi: 10.1055/s-0037-1604351. Epub 2017 Aug 24. PMID: 28837986; PMCID: PMC5910033.
- Plog BA, Nedergaard M. The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future. Annu Rev Pathol. 2018 Jan 24;13:379-394. doi: 10.1146/annurev-pathol-051217-111018. PMID: 29195051; PMCID: PMC5803388.
- Viggiano D, Wagner CA, Martino G, Nedergaard M, Zoccali C, Unwin R, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. (2020) 16:452–469. doi: 10.1038/s41581-020-0266-9
Stinghen AE, Pecoits-Filho R. Vascular damage in kidney disease: Beyond hypertension. Int J Hypertens. (2011) 2011:232683. doi: 10.4061/2011/232683
- De Deyn PP, Vanholder R, Eloot S, Glorieux G. Guanidino compounds as uremic (neuro)toxins. Semin Dial. 2009 Jul-Aug;22(4):340-5. doi: 10.1111/j.1525-139X.2009.00577.x. PMID: 19708978.
- Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol. 2001 Jul;12(7):1549-1557. doi: 10.1681/ASN.V1271549. PMID: 11423586.
- Shlipak MG, Fried LF, Crump C, Bleyer AJ, Manolio TA, Tracy RP, Furberg CD, Psaty BM. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003 Jan 7;107(1):87-92. doi: 10.1161/01.cir.0000042700.48769.59. PMID: 12515748.
- O'Lone E, Connors M, Masson P, Wu S, Kelly PJ, Gillespie D, et al. Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2016 Jun;67(6):925-35. doi: 10.1053/j.ajkd.2015.12.028. Epub 2016 Feb 23. PMID: 26919914..
- Sarnak MJ, Tighiouart H, Scott TM, Lou KV, Sorensen EP, Giang LM, Drew DA, Shaffi K, Strom JA, Singh AK, Weiner DE. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013 Jan 29;80(5):471-80. doi: 10.1212/WNL.0b013e31827f0f7f. Epub 2013 Jan 9. PMID: 23303848; PMCID: PMC3590049.
- Kurella Tamura M, Xie D, Yaffe K, Cohen DL, Teal V, Kasner SE, et al. Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study. Clin J Am Soc Nephrol. 2011 Feb;6(2):248-56. doi: 10.2215/CJN.02660310. Epub 2010 Oct 7. PMID: 20930087; PMCID: PMC3052213.
- Drew DA, Weiner DE, Tighiouart H, Scott T, Lou K, Kantor A, Fan L, Strom JA, Singh AK, Sarnak MJ. Cognitive function and all-cause mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2015 Feb;65(2):303-11. doi: 10.1053/j.ajkd.2014.07.009. Epub 2014 Sep 17. PMID: 25240262; PMCID: PMC4305473.
- Wang T, Xiao S, Chen K, Yang C, Dong S, Cheng Y, et al. Prevalence, Incidence, Risk and Protective Factors of Amnestic Mild Cognitive Impairment in the Elderly in Shanghai. Curr Alzheimer Res. 2017;14(4):460-466. doi: 10.2174/1567205013666161122094208. PMID: 27875948.
- van Zwieten A, Wong G, Ruospo M, Palmer SC, Barulli MR, Iurillo A, et al. COGNITIVE-HD study investigators. Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study. Nephrol Dial Transplant. 2018 Jul 1;33(7):1197-1206. doi: 10.1093/ndt/gfx314. PMID: 29186522.
- Gela, Y.Y., Fekadu, S.A., Belsti, Y. et al.Cognitive impairment and associated factors among mature and older adults living in the community of Gondar town, Ethiopia, 2020. Sci Rep 12, 7545 (2022). https://doi.org/10.1038/s41598-022-11735-2
- Tianyi FL, Agbor VN, Njamnshi AK, Atashili J. Factors Associated with the Prevalence of Cognitive Impairment in a Rural Elderly Cameroonian Population: A Community-Based Study in Sub-Saharan Africa. Dement Geriatr Cogn Disord. 2019;47(1-2):104-113. doi: 10.1159/000496825. Epub 2019 Apr 9. PMID: 30965322.
- Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, et al.. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):979-84. doi: 10.1136/jnnp.2007.136903. Epub 2008 May 1. PMID: 18450788.
- Guerchet M, M'belesso P, Mouanga AM, Bandzouzi B, Tabo A, Houinato DS, et al.. Prevalence of dementia in elderly living in two cities of Central Africa: the EDAC survey. Dement Geriatr Cogn Disord. 2010;30(3):261-8. doi: 10.1159/000320247. Epub 2010 Sep 16. PMID: 20847557.
- Jadenur, S. S., Saroja, A. O., Kari, A. & Angolkar, M. Prevalence of cognitive impairment among people aged ≥ 50 years in rural population of Belagavi Taluka—A community based cross sectional study. Epidemiol. Glob. Health 13, 100940 (2022).
- Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):979-84. doi: 10.1136/jnnp.2007.136903. Epub 2008 May 1. PMID: 18450788.
- Waldron N, et al. The prevalence of cognitive impairment among older adults in Jamaica. WIMJ Open https://doi.org/10.7727/ wimjopen.2014.003 (2015).
- Gela YY, Getu AA, Adane A, Ayal BM, Akalu Y, Ambelu A, Diress M, Yeshaw Y. Cognitive Impairment and Associated Factors Among Chronic Kidney Disease Patients: A Comparative Cross-Sectional Study. Neuropsychiatr Dis Treat. 2021 May 17;17:1483-1492. doi: 10.2147/NDT.S304543. PMID: 34040375; PMCID: PMC8139641.
- Miyazaki S, Kitamura M, Hayashida M, Tamaki A, Tomura H, Yamaguchi K, et al. Survival and cognitive deterioration in elderly patients undergoing hemodialysis. Geriatr Gerontol Int. 2023 Feb;23(2):111-116. doi: 10.1111/ggi.14531. Epub 2023 Jan 6. PMID: 36608644.
Figures: